GABARNANCE TRIAL
Randomized phase II/III study of gemcitabine and nab-paclitaxel therapy versus S-1 and concurrent radiotherapy as neoadjuvant treatment for Borderline resectable pancreatic cancer
JP
EN
Home
Sitemap
Sitemap
Home
Topics
About us・Member Institutions
Overview
Sitemap
Login